The effect of new drug approvals on HIV mortality in the US, 1987–1998
Bibliographic Data
| ID | 15448317 |
|---|---|
| Authors | Frank R Lichtenberg (0000-0002-5113-9681, Columbia University, corresponding author) |
| Year | 2003 |
| Volume | 1 |
| Issue | 2 |
| Pages | 259-266 |
| Publication date | 2003-05-19 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Economics & Human Biology (JOURNAL) |
| Journal identifiers | ISSN: 1570-677X • E-ISSN: 1873-6130 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/s1570-677x(02)00031-x |
| PMID | 15463977 |
| OpenAlex | W2053293953 |
| Language | EN |
| Citations received | 5 |
| References cited | 6 |
Drug · Human immunodeficiency virus (HIV · Demography · HIV Research and Treatment · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Immunology · Pharmacology
The intended and unintended results of medical innovation and innovation race
The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009
Black-white disparities during an epidemic
Antiretroviral therapy and demand for HIV testing
(In)-Equality in the Allocation of R&D Resources for Rare Diseases
| Citations per year | 0.38 |
|---|---|
| Citation span | 2013 - 2025 (13) |
| Highly cited | No |